- Report
- October 2024
- 186 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- July 2023
- 99 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
Acetohydroxamic Acid is a drug used to treat urological disorders, such as urinary tract infections and kidney stones. It works by inhibiting the enzyme urease, which is responsible for the breakdown of urea into ammonia. This reduces the amount of ammonia in the urine, which helps to reduce the risk of infection. Acetohydroxamic Acid is available in both oral and intravenous forms. It is generally well tolerated, with few side effects.
Acetohydroxamic Acid is used in combination with other drugs to treat urological disorders. It is often prescribed in combination with antibiotics, such as ciprofloxacin, to treat urinary tract infections. It is also used in combination with other drugs to treat kidney stones.
The Acetohydroxamic Acid market is highly competitive, with several companies offering products. Some of the major players in the market include Pfizer, Merck, Novartis, and AstraZeneca. Show Less Read more